US Stock MarketDetailed Quotes

Vera Therapeutics (VERA)

Watchlist

39.150
+2.450+6.68%

Close May 13 16:00 ET

39.000
-0.150-0.38%

Pre 06:01 ET

2.81BMarket Cap-7.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vera Therapeutics (VERA) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-95.75%-106.5M

-79.02%-241.1M

-78.64%-69.99M

-67.84%-61.91M

-121.12%-54.8M

-60.82%-54.41M

-46.10%-134.68M

-55.83%-39.18M

-60.56%-36.89M

-39.44%-24.78M

Net income from continuing operations

-134.13%-121.03M

-96.92%-299.62M

-109.78%-91.1M

-72.18%-80.29M

-127.04%-76.53M

-82.13%-51.69M

-58.50%-152.15M

-69.27%-43.43M

-131.95%-46.63M

-67.19%-33.71M

Depreciation and amortization

64.71%140K

345.71%468K

145.45%135K

437.50%129K

693.33%119K

672.73%85K

400.00%105K

1,275.00%55K

300.00%24K

-97.10%15K

Other non cash items

1,003.29%15.76M

42.87%4.11M

-1.96%750K

81.79%1.28M

-7.14%650K

102.27%1.43M

12.71%2.87M

22.20%765K

11.94%703K

-2.37%700K

Change In working capital

-45.45%-13.73M

764.36%22.99M

1,523.35%10.36M

48.15%8.69M

117.81%13.38M

-9.50%-9.44M

145.69%2.66M

64.92%-728K

219.68%5.86M

5,242.61%6.14M

-Change in prepaid assets

12.47%-5.14M

-500.41%-3.93M

-175.00%-372K

132.88%606K

-36.99%1.71M

-1,398.98%-5.88M

467.05%981K

-38.69%496K

11.69%-1.84M

218.36%2.72M

-Change in payables and accrued expense

-163.83%-8.4M

659.09%28.35M

1,638.78%10.83M

8.80%8.71M

197.37%12M

58.09%-3.19M

220.95%3.74M

68.52%-704K

468.51%8M

20.49%4.03M

-Change in other current assets

--0

-85.47%51K

-88.89%1K

-133.75%-108K

984.62%141K

88.89%17K

233.97%351K

800.00%9K

2,809.09%320K

104.81%13K

-Change in other current liabilities

53.81%-182K

38.39%-1.48M

81.10%-100K

15.86%-520K

24.72%-469K

38.15%-394K

9.00%-2.41M

18.49%-529K

5.07%-618K

6.32%-623K

Cash from discontinued investing activities

Operating cash flow

-95.75%-106.5M

-79.02%-241.1M

-78.64%-69.99M

-67.84%-61.91M

-121.12%-54.8M

-60.82%-54.41M

-46.10%-134.68M

-55.83%-39.18M

-60.56%-36.89M

-39.44%-24.78M

Investing cash flow

Cash flow from continuing investing activities

-999.76%-137.82M

145.71%194.29M

136.44%80.66M

82.06%69.76M

225.87%28.54M

106.98%15.32M

-977.91%-425.03M

-1,293.05%-221.38M

136.12%38.32M

73.77%-22.68M

Net PPE purchase and sale

87.70%-23K

35.19%-630K

84.19%-102K

44.12%-133K

-133.71%-208K

---187K

-1,442.86%-972K

-923.81%-645K

---238K

---89K

Net intangibles purchase and sale

---150K

----

--0

----

Net investment purchase and sale

-854.54%-122.64M

146.15%195.72M

136.59%80.77M

81.28%69.89M

227.51%28.8M

107.41%16.25M

-977.16%-424.06M

-1,285.55%-220.74M

137.58%38.56M

73.87%-22.59M

Net other investing changes

-1,900.00%-15M

---800K

--0

---50K

---750K

----

Cash from discontinued investing activities

Investing cash flow

-999.76%-137.82M

145.71%194.29M

136.44%80.66M

82.06%69.76M

225.87%28.54M

106.98%15.32M

-977.91%-425.03M

-1,293.05%-221.38M

136.12%38.32M

73.77%-22.68M

Financing cash flow

Cash flow from continuing financing activities

157.14%3.94M

-49.08%308.9M

-12.17%286.28M

7.85%797K

489.85%20.29M

-99.45%1.53M

354.30%606.67M

1,212.85%325.96M

148.82%739K

696.06%3.44M

Net issuance payments of debt

----

--23.34M

--0

----

--0

----

Net common stock issuance

----

-52.49%300.5M

-12.90%300.5M

--0

450.02%632.52M

--345M

---13K

--0

Proceeds from stock option exercised by employees

157.14%3.94M

-47.95%6.98M

81.18%4.19M

5.98%797K

-86.51%464K

-77.82%1.53M

1,170.17%13.41M

2,556.32%2.31M

153.20%752K

696.06%3.44M

Net other financing activities

----

44.17%-21.92M

13.82%-18.41M

--0

----

-441.12%-39.26M

---21.36M

--0

Cash from discontinued financing activities

Financing cash flow

157.14%3.94M

-49.08%308.9M

-12.17%286.28M

7.85%797K

489.85%20.29M

-99.45%1.53M

354.30%606.67M

1,212.85%325.96M

148.82%739K

696.06%3.44M

Net cash flow

Beginning cash position

282.88%354.73M

102.81%92.65M

111.96%57.77M

95.82%49.12M

-20.28%55.09M

102.81%92.65M

4.41%45.68M

-0.67%27.26M

-25.98%25.09M

-49.81%69.11M

Current changes in cash

-540.04%-240.37M

458.03%262.08M

354.12%296.95M

298.53%8.65M

86.44%-5.97M

-260.33%-37.56M

2,334.68%46.97M

258.50%65.39M

133.67%2.17M

57.59%-44.02M

End cash Position

107.57%114.35M

282.88%354.73M

111.96%57.77M

95.82%49.12M

-20.28%55.09M

102.81%92.65M

-0.67%27.26M

-25.98%25.09M

Free cash flow

-95.40%-106.67M

-78.20%-241.73M

-76.00%-70.1M

-67.12%-62.04M

-121.17%-55.01M

-61.37%-54.59M

-47.06%-135.65M

-58.00%-39.83M

-61.59%-37.12M

-39.94%-24.87M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-95.75%-106.5M	-79.02%-241.1M	-78.64%-69.99M	-67.84%-61.91M	-121.12%-54.8M	-60.82%-54.41M	-46.10%-134.68M	-55.83%-39.18M	-60.56%-36.89M	-39.44%-24.78M
Net income from continuing operations	-134.13%-121.03M	-96.92%-299.62M	-109.78%-91.1M	-72.18%-80.29M	-127.04%-76.53M	-82.13%-51.69M	-58.50%-152.15M	-69.27%-43.43M	-131.95%-46.63M	-67.19%-33.71M
Depreciation and amortization	64.71%140K	345.71%468K	145.45%135K	437.50%129K	693.33%119K	672.73%85K	400.00%105K	1,275.00%55K	300.00%24K	-97.10%15K
Other non cash items	1,003.29%15.76M	42.87%4.11M	-1.96%750K	81.79%1.28M	-7.14%650K	102.27%1.43M	12.71%2.87M	22.20%765K	11.94%703K	-2.37%700K
Change In working capital	-45.45%-13.73M	764.36%22.99M	1,523.35%10.36M	48.15%8.69M	117.81%13.38M	-9.50%-9.44M	145.69%2.66M	64.92%-728K	219.68%5.86M	5,242.61%6.14M
-Change in prepaid assets	12.47%-5.14M	-500.41%-3.93M	-175.00%-372K	132.88%606K	-36.99%1.71M	-1,398.98%-5.88M	467.05%981K	-38.69%496K	11.69%-1.84M	218.36%2.72M
-Change in payables and accrued expense	-163.83%-8.4M	659.09%28.35M	1,638.78%10.83M	8.80%8.71M	197.37%12M	58.09%-3.19M	220.95%3.74M	68.52%-704K	468.51%8M	20.49%4.03M
-Change in other current assets	--0	-85.47%51K	-88.89%1K	-133.75%-108K	984.62%141K	88.89%17K	233.97%351K	800.00%9K	2,809.09%320K	104.81%13K
-Change in other current liabilities	53.81%-182K	38.39%-1.48M	81.10%-100K	15.86%-520K	24.72%-469K	38.15%-394K	9.00%-2.41M	18.49%-529K	5.07%-618K	6.32%-623K
Cash from discontinued investing activities
Operating cash flow	-95.75%-106.5M	-79.02%-241.1M	-78.64%-69.99M	-67.84%-61.91M	-121.12%-54.8M	-60.82%-54.41M	-46.10%-134.68M	-55.83%-39.18M	-60.56%-36.89M	-39.44%-24.78M
Investing cash flow
Cash flow from continuing investing activities	-999.76%-137.82M	145.71%194.29M	136.44%80.66M	82.06%69.76M	225.87%28.54M	106.98%15.32M	-977.91%-425.03M	-1,293.05%-221.38M	136.12%38.32M	73.77%-22.68M
Net PPE purchase and sale	87.70%-23K	35.19%-630K	84.19%-102K	44.12%-133K	-133.71%-208K	---187K	-1,442.86%-972K	-923.81%-645K	---238K	---89K
Net intangibles purchase and sale	---150K	----	----	----	----	--0	----	----	----	----
Net investment purchase and sale	-854.54%-122.64M	146.15%195.72M	136.59%80.77M	81.28%69.89M	227.51%28.8M	107.41%16.25M	-977.16%-424.06M	-1,285.55%-220.74M	137.58%38.56M	73.87%-22.59M
Net other investing changes	-1,900.00%-15M	---800K	--0	--0	---50K	---750K	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-999.76%-137.82M	145.71%194.29M	136.44%80.66M	82.06%69.76M	225.87%28.54M	106.98%15.32M	-977.91%-425.03M	-1,293.05%-221.38M	136.12%38.32M	73.77%-22.68M
Financing cash flow
Cash flow from continuing financing activities	157.14%3.94M	-49.08%308.9M	-12.17%286.28M	7.85%797K	489.85%20.29M	-99.45%1.53M	354.30%606.67M	1,212.85%325.96M	148.82%739K	696.06%3.44M
Net issuance payments of debt	----	--23.34M	--0	--0	----	----	--0	--0	--0	----
Net common stock issuance	----	-52.49%300.5M	-12.90%300.5M	--0	--0	--0	450.02%632.52M	--345M	---13K	--0
Proceeds from stock option exercised by employees	157.14%3.94M	-47.95%6.98M	81.18%4.19M	5.98%797K	-86.51%464K	-77.82%1.53M	1,170.17%13.41M	2,556.32%2.31M	153.20%752K	696.06%3.44M
Net other financing activities	----	44.17%-21.92M	13.82%-18.41M	--0	----	----	-441.12%-39.26M	---21.36M	--0	--0
Cash from discontinued financing activities
Financing cash flow	157.14%3.94M	-49.08%308.9M	-12.17%286.28M	7.85%797K	489.85%20.29M	-99.45%1.53M	354.30%606.67M	1,212.85%325.96M	148.82%739K	696.06%3.44M
Net cash flow
Beginning cash position	282.88%354.73M	102.81%92.65M	111.96%57.77M	95.82%49.12M	-20.28%55.09M	102.81%92.65M	4.41%45.68M	-0.67%27.26M	-25.98%25.09M	-49.81%69.11M
Current changes in cash	-540.04%-240.37M	458.03%262.08M	354.12%296.95M	298.53%8.65M	86.44%-5.97M	-260.33%-37.56M	2,334.68%46.97M	258.50%65.39M	133.67%2.17M	57.59%-44.02M
End cash Position	107.57%114.35M	282.88%354.73M	282.88%354.73M	111.96%57.77M	95.82%49.12M	-20.28%55.09M	102.81%92.65M	102.81%92.65M	-0.67%27.26M	-25.98%25.09M
Free cash flow	-95.40%-106.67M	-78.20%-241.73M	-76.00%-70.1M	-67.12%-62.04M	-121.17%-55.01M	-61.37%-54.59M	-47.06%-135.65M	-58.00%-39.83M	-61.59%-37.12M	-39.94%-24.87M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm